Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial

BACKGROUND: 2-Hydroxybenzylamine (2-HOBA) is a selective dicarbonyl electrophile scavenger being developed as a nutritional supplement to help protect against the development of conditions associated with dicarbonyl electrophile formation, such as the cognitive decline observed with Mild Cognitive I...

Descripción completa

Detalles Bibliográficos
Autores principales: Pitchford, Lisa M., Driver, Patricia M., Fuller, John C., Akers, Wendell S., Abumrad, Naji N., Amarnath, Venkataraman, Milne, Ginger L., Chen, Sheau-Chiann, Ye, Fei, Roberts, L. Jackson, Shoemaker, M. Benjamin, Oates, John A., Rathmacher, John A., Boutaud, Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945443/
https://www.ncbi.nlm.nih.gov/pubmed/31907026
http://dx.doi.org/10.1186/s40360-020-0382-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945443/
https://www.ncbi.nlm.nih.gov/pubmed/31907026
http://dx.doi.org/10.1186/s40360-020-0382-y

Ejemplares similares